US-approved vaccines effective against B1617 variant of Covid-19: US health official

WHO classified the B1617 SARS-CoV-2 variant, and confirmed that the variant was first detected in India

Comments

Popular posts from this blog

Congress groomed me not to sit at home: Shivakumar

Infosys lays off hundreds after failing internal assessments in Mysuru

K’taka police announce Rs 5 lakh reward for Bidar ATM guard, Afzalgunj shooters